Nia Tatsis

Nia Tatsis

EVP & Chief Regulatory and Quality OfficeratVertex Pharmaceuticals Inc / Ma· In proxies 2024–2025

Pay in FY2025-5% from the year before · Vertex Pharmaceuticals Inc / Ma stock +12.6% the same year

Nia Tatsis was paid $7.0M in FY2025 (Dec), down 5%. Vertex Pharmaceuticals Inc / Ma stock rose 12.6% that year.

Pay$100 in the stock at the end of FY23 → $111
Pay is from the Summary Compensation Table of each Vertex Pharmaceuticals Inc / Ma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Vertex Pharmaceuticals Inc / MaPublic company · 2 yr
    • EVP & Chief Regulatory and Quality Officer2024 – Present · 2 yrStock in role +30%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?